Results for tag: "Mecasermin"

Mecasermin is a recombinant human insulin-like growth factor-1 (IGF-1) used to treat growth failure in children with severe primary IGF-1 deficiency. It is a hormone that helps the body to grow and develop normally. It is used to treat growth failure in children with severe primary IGF-1 deficiency, a rare condition in which the body does not produce enough IGF-1. Mecasermin is also used to treat short stature associated with Turner syndrome, a genetic disorder that affects growth and development in girls. Mecasermin is a part of the Endocrine and Metabolic Disorders Drugs market, which includes drugs used to treat endocrine and metabolic disorders such as diabetes, thyroid disorders, and obesity. These drugs are used to regulate hormones, control blood sugar levels, and reduce cholesterol levels. Companies in the Mecasermin market include Novo Nordisk, Eli Lilly, Sanofi, Merck, and Pfizer. Show Less Read more